News & Updates
Filter by Specialty:
Intensive testosterone-blocking therapy delays prostate-specific antigen progression in BRPC
A 52-week course of intensified androgen-deprivation therapy (ADT) appears to extend prostate-specific antigen progression-free survival (PSA-PFS) in patients with biochemically recurrent prostate cancer (BRPC) compared with ADT alone, without prolonging time to testosterone recovery, according to the phase III open-label PRESTO trial.
Intensive testosterone-blocking therapy delays prostate-specific antigen progression in BRPC
31 Jan 2024
Aqueous shunts with extraocular reservoir lower IOP in adults with OAG
Adults with open-angle glaucoma (OAG) may benefit from the implantation of aqueous shunts with extraocular reservoir, including valved or nonvalved devices, which can reduce intraocular pressure (IOP), as shown in a study.
Aqueous shunts with extraocular reservoir lower IOP in adults with OAG
31 Jan 2024
Noncontrast-enhanced MRI superior to US but less cost-effective for HCC screening
Noncontrast-enhanced magnetic resonance imaging (NCEMRI) demonstrates superiority over ultrasonography (US) for the surveillance of hepatocellular carcinoma (HCC) in at-risk populations, although this strategy is more expensive than US, according to a Singapore study.
Noncontrast-enhanced MRI superior to US but less cost-effective for HCC screening
31 Jan 2024
Self-adjusted nitrous oxide eases pain during transrectal prostate biopsy
Patient use of self-adjusted nitrous oxide (N2O) at levels of 20 percent to 45 percent during transrectal prostate biopsy is safe and well tolerated, according to a study. Delivery of low-dose N2O is associated with reduced pain, but its effect on anxiety does not seem significant.